Galactomannan Downregulates the Inflammation Responses in Human Macrophages via NFκB2/p100

Mediators Inflamm. 2015:2015:942517. doi: 10.1155/2015/942517. Epub 2015 Sep 9.

Abstract

We show that galactomannan, a polysaccharide consisting of a mannose backbone with galactose side groups present on the cell wall of several fungi, induces a reprogramming of the inflammatory response in human macrophages through dectin-1 receptor. The nuclear factor kappa-light-chain-enhancer of activated B cells 2 (NFκB2)/p100 was overexpressed after galactomannan challenge. Knocking down NFκB2/p100 using small interfering RNA (siRNA) indicated that NFκB2/p100 expression is a crucial factor in the progression of the galactomannan-induced refractoriness. The data presented in this study could be used as a modulator of inflammatory response in clinical situations where refractory state is required.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Flow Cytometry
  • Galactose / analogs & derivatives
  • Humans
  • Inflammation / chemically induced
  • Inflammation / drug therapy*
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects*
  • Macrophages / immunology*
  • Mannans / therapeutic use*
  • NF-kappa B p52 Subunit / metabolism*
  • RNA, Small Interfering

Substances

  • Lipopolysaccharides
  • Mannans
  • NF-kappa B p52 Subunit
  • RNA, Small Interfering
  • galactomannan
  • Galactose